In fact, says RobertMayerRobertMayer , director for the center of gastrointestinal oncology at the Dana-Farber Cancer Center, the statins are enticing but less promising than other drugs developed more specifically for cancer.
" Says RobertMayer , director of the center for gastrointestinal oncology at the Dana-Farber Cancer Institute: "I think it's hard to be anything but enthusiastic about the results.